View : 702 Download: 179

Full metadata record

DC Field Value Language
dc.contributor.author이대기*
dc.date.accessioned2016-08-28T10:08:50Z-
dc.date.available2016-08-28T10:08:50Z-
dc.date.issued2013*
dc.identifier.issn1932-6203*
dc.identifier.otherOAK-10006*
dc.identifier.urihttps://dspace.ewha.ac.kr/handle/2015.oak/223653-
dc.description.abstractMyeloperoxidase (MPO) functions as a key molecular component of the host defense system against diverse pathogens. We have previously reported that increased MPO levels and activity is a distinguishing feature of rotenone-exposed glial cells, and that either overactivation or deficiency of MPO leads to pathological conditions in the brain. Here, we provide that modulation of MPO levels in glia by resveratrol confers protective effects on rotenone-induced neurotoxicity. We show that resveratrol significantly reduced MPO levels but did not trigger abnormal nitric oxide (NO) production in microglia and astrocytes. Resveratrol-induced down-regulation of MPO, in the absence of an associated overproduction of NO, markedly attenuated rotenone-triggered inflammatory responses including phagocytic activity and reactive oxygen species production in primary microglia and astrocytes. In addition, impaired responses of primary mixed glia from Mpo-/- mice to rotenone were relieved by treatment with resveratrol. We further show that rotenone-induced neuronal injury, particularly dopaminergic cell death, was attenuated by resveratrol in neuron-glia co-cultures, but not in neurons cultured alone. Similar regulatory effects of resveratrol on MPO levels were observed in microglia treated with MPP+, another Parkinson's disease-linked neurotoxin, supporting the beneficial effects of resveratrol on the brain. Collectively, our findings provide that resveratrol influences glial responses to rotenone by regulating both MPO and NO, and thus protects against rotenone-induced neuronal injury. © 2013 Chang et al.*
dc.languageEnglish*
dc.titleResveratrol Confers Protection against Rotenone-Induced Neurotoxicity by Modulating Myeloperoxidase Levels in Glial Cells*
dc.typeArticle*
dc.relation.issue4*
dc.relation.volume8*
dc.relation.indexSCIE*
dc.relation.indexSCOPUS*
dc.relation.journaltitlePLoS ONE*
dc.identifier.doi10.1371/journal.pone.0060654*
dc.identifier.wosidWOS:000317898000046*
dc.identifier.scopusid2-s2.0-84875970786*
dc.author.googleChang C.Y.*
dc.author.googleChoi D.-K.*
dc.author.googleLee D.K.*
dc.author.googleHong Y.J.*
dc.author.googlePark E.J.*
dc.contributor.scopusid이대기(37047040400)*
dc.date.modifydate20231120165418*


qrcode

BROWSE